Metraipolis › archive › dc_dd4934ddbcb3

Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer — Europe PMC PMID:41233923

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41233923
DOI
10.1186/s13058-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-08T14:39:20.524Z
SHA-256 of the archived text
29b106cd984bb815e220731e6e73f302ca59a344cd9c7b1bfeeb27e7b81f286e
Stable URL of this page
https://metraipolis.com/documento/dc_dd4934ddbcb3

How to cite

Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer — Europe PMC PMID:41233923 — Europe PMC (en), https://europepmc.org/article/MED/41233923 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dd4934ddbcb3 (Metraipolis archive dc_dd4934ddbcb3, sha256 29b106cd984bb815e220731e6e73f302ca59a344cd9c7b1bfeeb27e7b81f286e)
BibTeX
@misc{dcdd4934ddbcb3,
  title = {Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer — Europe PMC PMID:41233923},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41233923},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dd4934ddbcb3; sha256 29b106cd984bb815e220731e6e73f302ca59a344cd9c7b1bfeeb27e7b81f286e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41233923. Agents can read the archived copy with the MCP tool read_document.